Pages that link to "Q61862503"
Jump to navigation
Jump to search
The following pages link to Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat-selective MRI and volume-localized1H-MR spectroscopy (Q61862503):
Displaying 50 items.
- Excess body fat in obese and normal-weight subjects (Q28746115) (← links)
- Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial (Q30278529) (← links)
- Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods. (Q30361971) (← links)
- Parametric exploration of the liver by magnetic resonance methods (Q30485888) (← links)
- Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study (Q30563967) (← links)
- Contrast in static images in clinical magnetic resonance imaging. Part 2: Sequences for various contrast weightings and applications (Q30661647) (← links)
- Quantitative proton MR techniques for measuring fat (Q30677112) (← links)
- Age- and Gender Dependent Liver Fat Content in a Healthy Normal BMI Population as Quantified by Fat-Water Separating DIXON MR Imaging (Q31020766) (← links)
- Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. (Q31147984) (← links)
- Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. (Q33409801) (← links)
- Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction (Q33412471) (← links)
- Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy (Q33413130) (← links)
- Myocardial fat quantification in humans: Evaluation by two-point water-fat imaging and localized proton spectroscopy (Q33550436) (← links)
- Evaluation of subchondral bone marrow lipids of acute anterior cruciate ligament (ACL)-injured patients at 3 T (Q33682286) (← links)
- Assessment of relevant hepatic steatosis in obese adolescents by rapid fat-selective GRE imaging with spatial-spectral excitation: a quantitative comparison with spectroscopic findings (Q33709013) (← links)
- Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy (Q33797528) (← links)
- Optimized in-phase and opposed-phase MR imaging for accurate detection of small fat or water fractions: theoretical considerations and experimental application in emulsions (Q33856909) (← links)
- Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla (Q33879999) (← links)
- Common genetic variation in the human CTF1 locus, encoding cardiotrophin-1, determines insulin sensitivity (Q33904645) (← links)
- Overload hepatitides: quanti-qualitative analysis (Q33924051) (← links)
- Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms (Q33965161) (← links)
- 1H−MRS of hepatic fat using short TR at 3T: SNR optimization and fast T2 relaxometry (Q34011170) (← links)
- ISMRM workshop on fat-water separation: insights, applications and progress in MRI. (Q34302041) (← links)
- Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment (Q34504586) (← links)
- Metabolic syndrome and hepatic resection: improving outcome (Q35629684) (← links)
- Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers (Q35866957) (← links)
- Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content (Q35883812) (← links)
- Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors (Q36743255) (← links)
- Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment (Q37149405) (← links)
- Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids (Q37150162) (← links)
- Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents (Q37359632) (← links)
- Noninvasive assessment of hepatic steatosis. (Q37360964) (← links)
- Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (Q37581357) (← links)
- Liver fat content determined by magnetic resonance imaging and spectroscopy (Q37721939) (← links)
- Recent advances in imaging hepatic fibrosis and steatosis (Q37839093) (← links)
- Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology (Q40147031) (← links)
- IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet (Q41627727) (← links)
- Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study (Q43131995) (← links)
- Comparison of vertebral bone marrow fat assessed by 1H MRS and inphase and out-of-phase MRI among family members. (Q46626221) (← links)
- A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study (Q47312991) (← links)
- Association of pericardial fat with liver fat and insulin sensitivity after diet-induced weight loss in overweight women. (Q47441354) (← links)
- Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet (Q48134374) (← links)
- Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial (Q48259132) (← links)
- Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging (Q51901149) (← links)
- Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes. (Q53549279) (← links)
- Repeatability of two-dimensional chemical shift imaging multivoxel proton magnetic resonance spectroscopy for measuring human cerebral choline-containing compounds. (Q54250326) (← links)
- Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. (Q54617558) (← links)
- Obesity, metabolic disease and the pancreas—Quantitative imaging of pancreatic fat (Q57943356) (← links)
- Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial (Q61862450) (← links)
- Choline Supplementation in Cystic Fibrosis-The Metabolic and Clinical Impact (Q64081780) (← links)